Eveline Jaquenoud is since 2000 director for Pharmacovigilance, Drug Interactions, Pharmacogenetics, and Quality Assurance (mediQ) at the largest psychiatric hospital (Klinik Königsfelden) in Switzerland. Before, she worked during 12 years for Solvay as medical director and member of the management board. 

E. Jaquenoud is Past President of the Swiss AMSP society (Pharmacovigilance in Psychiatry), and among others member of the AGNP TDM-expert group (Therapeutic Drug Monitoring), ISOP (International Society for Pharmacovigilance) and the Swiss Society for Biological Psychiatry. 

She is frequently invited to teach on personalised medicine with a focus on Therapeutic Drug Monitoring and knowledge on drug-drug interactions and pharmacogenetics on international conferences, and also published numerous articles in peer-reviewed journals. 

Dr Jaquenoud studied biology at the Universities of Zurich and Lausanne with a specialization in genetics. She developed the online Interaction Program mediQ (www.mediq.ch).


Back to Associated Experts